The store will not work correctly when cookies are disabled.
4-[3-(4-Methylphenyl)-4-methyl-5-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
ID: ALA1086120
PubChem CID: 46889872
Max Phase: Preclinical
Molecular Formula: C19H14F3N3OS
Molecular Weight: 389.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2C)cc1
Standard InChI: InChI=1S/C19H14F3N3OS/c1-11-3-6-14(7-4-11)24-12(2)17(26)25(18(24)27)15-8-5-13(10-23)16(9-15)19(20,21)22/h3-9,12H,1-2H3
Standard InChI Key: PMASOZJHVUSLNM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
6.5861 2.4209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5849 1.5935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2997 1.1806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0162 1.5940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0133 2.4245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2979 2.8336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8704 2.8390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1558 3.2513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8701 1.1816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1560 1.5946 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.8695 0.3566 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.6572 1.9786 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.6838 1.1170 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6911 0.2920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4780 0.0440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9570 0.7157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4662 1.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0280 -0.1988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7141 2.1656 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.7809 0.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2009 0.0123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0259 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4320 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0070 1.4539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1834 1.4420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2569 0.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7398 -0.7383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
3 4 2 0
7 8 3 0
1 7 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
4 13 1 0
14 18 2 0
2 9 1 0
17 19 2 0
16 20 1 0
4 5 1 0
9 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
9 11 1 0
22 23 2 0
5 6 2 0
23 24 1 0
9 12 1 0
24 25 2 0
25 20 1 0
13 14 1 0
23 26 1 0
6 1 1 0
15 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 389.40 | Molecular Weight (Monoisotopic): 389.0810 | AlogP: 4.41 | #Rotatable Bonds: 2 |
Polar Surface Area: 47.34 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.84 | CX Basic pKa: ┄ | CX LogP: 5.02 | CX LogD: 5.02 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -1.45 |
References
1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.. (2010) Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)., 53 (7): [PMID:20218717] [10.1021/jm901488g] |